Status:
ENROLLING_BY_INVITATION
Symptom-Based Markers for COVID-19 Transmission
Lead Sponsor:
University of Iowa
Conditions:
Covid19
Eligibility:
All Genders
18-100 years
Brief Summary
In this study, COVID-19 positive patients will be added to a bidirectional texting program to receive daily surveys about their symptoms with the infection. This data will further the understanding of...
Detailed Description
One important approach for decreasing COVID-19 transmission in healthcare settings is to prevent healthcare professionals from working while ill. Currently, facilities are asking screening questions a...
Eligibility Criteria
Inclusion
- Fluent in English
- Tested positive for COVID-19
Exclusion
- Prisoners
- Unable to provide own informed consent
Key Trial Info
Start Date :
December 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04665245
Start Date
December 15 2020
End Date
December 1 2025
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Hospitals & Clinics
Iowa City, Iowa, United States, 52242